A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV)
Telaprevir in Genotype 3 HCV
Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients
Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC Polymorphism
Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir
Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection
† Study has passed its completion date and status has not been verified in more than two years.